【摘要】：目的探討臨床治療三叉神經(jīng)痛的阿霉素最佳濃度。方法入組對象為2014年5月至2017年5月入住本院的90例PTN患者,均符合2004年國際頭痛學(xué)分會分類委員會制定的《頭痛的國際分類》中關(guān)于PTN的臨床診斷標(biāo)準(zhǔn)。將其按照治療方法分為Ⅰ、Ⅱ、Ⅲ組,各為30例。分別采用0.33%及0.50%及1.0%濃度的阿霉素進行治療,比較三組臨床療效。結(jié)果 (1)3組組治療后VAS疼痛評分均顯著小于治療前(P0.05),且Ⅱ、Ⅲ組患者治療后VAS評分顯著小于Ⅰ組治療后(P0.05);(2)經(jīng)治療后,Ⅰ組臨床總有效率為73.33%(22/30),Ⅱ組為96.67%(29/30),Ⅲ組為96.67%(29/30),Ⅱ、Ⅲ組患者治療療效顯著優(yōu)于Ⅰ組(P0.05)。結(jié)論 0.5%及1.0%濃度的阿霉素治療PTN的療效及安全性均較高,應(yīng)在臨床中進行推廣。
[Abstract]:Objective to investigate the optimal concentration of doxorubicin in clinical treatment of trigeminal neuralgia. Methods 90 PTN patients admitted to our hospital from May 2014 to May 2017 were enrolled in the study. All of them met the clinical diagnostic criteria of PTN in the International Classification of headache established by the International Classification of headache in 2004. According to the treatment method, they were divided into three groups, 30 cases in each group. The clinical effects of 0.33% and 0.50% and 1.0% doxorubicin were compared among the three groups. Results (1) the VAS pain score of the three groups after treatment was significantly lower than that before treatment (P 0.05), and the VAS score of the patients in group II and III after treatment was significantly lower than that after treatment in group 鈪，

本文編號：2501903